128 related articles for article (PubMed ID: 2096993)
1. Progesterone antagonists block the growth of experimental mammary tumors in G0/G1.
Michna H; Schneider M; Nishino Y; el Etreby MF; McGuire WL
Breast Cancer Res Treat; 1990 Dec; 17(2):155-6. PubMed ID: 2096993
[No Abstract] [Full Text] [Related]
2. A bioassay for the evaluation of antiproliferative potencies of progesterone antagonists.
Michna H; Nishino Y; Schneider MR; Louton T; el Etreby MF
J Steroid Biochem Mol Biol; 1991 Mar; 38(3):359-65. PubMed ID: 1706934
[TBL] [Abstract][Full Text] [Related]
3. The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell death.
Michna H; Schneider MR; Nishino Y; el Etreby MF
J Steroid Biochem; 1989; 34(1-6):447-53. PubMed ID: 2626038
[TBL] [Abstract][Full Text] [Related]
4. The antitumor potency of progesterone antagonists is due to their differentiation potential.
Michna H; Gehring S; Kühnel W; Nishino Y; Schneider MR
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):203-10. PubMed ID: 1525061
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity and mechanism of action of different antiprogestins in experimental breast cancer models.
Schneider MR; Michna H; Nishino Y; el Etreby MF
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):783-7. PubMed ID: 2285591
[TBL] [Abstract][Full Text] [Related]
6. Tumor-inhibiting potential of ZK 112.993, a new progesterone antagonist, in hormone-sensitive, experimental rodent and human mammary tumors.
Schneider MR; Michna H; Nishino Y; Neef G; el Etreby MF
Anticancer Res; 1990; 10(3):683-7. PubMed ID: 2369083
[TBL] [Abstract][Full Text] [Related]
7. Failure of two progesterone antagonists, mifepristone and onapristone, to affect luteal activity in lactating rats.
van der Schoot P; Uilenbroek JT; Slappendel EJ
J Reprod Fertil; 1989 Nov; 87(2):593-601. PubMed ID: 2513392
[TBL] [Abstract][Full Text] [Related]
8. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).
Groshong SD; Owen GI; Grimison B; Schauer IE; Todd MC; Langan TA; Sclafani RA; Lange CA; Horwitz KB
Mol Endocrinol; 1997 Oct; 11(11):1593-607. PubMed ID: 9328342
[TBL] [Abstract][Full Text] [Related]
9. Progesterone antagonists: tumor-inhibiting potential and mechanism of action.
Michna H; Nishino Y; Neef G; McGuire WL; Schneider MR
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):339-48. PubMed ID: 1562510
[TBL] [Abstract][Full Text] [Related]
10. Morphology of the rat uterus after long-term treatment with progesterone antagonists.
Rumpel E; Michna H; Kühnel W
Ann Anat; 1993 Apr; 175(2):141-9. PubMed ID: 8489034
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha.
Goya L; Maiyar AC; Ge Y; Firestone GL
Mol Endocrinol; 1993 Sep; 7(9):1121-32. PubMed ID: 8247014
[TBL] [Abstract][Full Text] [Related]
12. Non-genomic effects of progestins--inhibition of cell growth and increased intracellular levels of cyclic nucleotides.
Sager G; Ørbo A; Jaeger R; Engström C
J Steroid Biochem Mol Biol; 2003 Jan; 84(1):1-8. PubMed ID: 12648518
[TBL] [Abstract][Full Text] [Related]
13. The tumour-inhibiting potential of the progesterone antagonist Onapristone in the human mammary carcinoma T61 in nude mice.
Schneider MR; Michna H; Habenicht UF; Nishino Y; Grill HJ; Pollow K
J Cancer Res Clin Oncol; 1992; 118(3):187-9. PubMed ID: 1548283
[TBL] [Abstract][Full Text] [Related]
14. [Effects of progesterone antagonists on the eosinophilic granulocytes in the rat uterus].
Schubert AK
Ann Anat; 1998 Oct; 180(5):401-8. PubMed ID: 9795690
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist.
Fuhrmann U; Hess-Stumpp H; Cleve A; Neef G; Schwede W; Hoffmann J; Fritzemeier KH; Chwalisz K
J Med Chem; 2000 Dec; 43(26):5010-6. PubMed ID: 11150172
[TBL] [Abstract][Full Text] [Related]
16. Modulation of oestrogenic effects by progesterone antagonists in the rat uterus.
Chwalisz K; Stöckemann K; Fritzemeier KH; Fuhrmann U
Hum Reprod Update; 1998; 4(5):570-83. PubMed ID: 10027611
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin-14 and its analog octreotide exert a cytostatic effect on GH3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block.
Cheung NW; Boyages SC
Endocrinology; 1995 Oct; 136(10):4174-81. PubMed ID: 7664634
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues.
Lin VC; Aw SE; Ng EH; Ng EH; Tan MG
Br J Cancer; 2001 Dec; 85(12):1978-86. PubMed ID: 11747343
[TBL] [Abstract][Full Text] [Related]
19. [Antiprogestins].
Sergeev PV; Kareva EN; Tkacheva NIu; Vysotskiĭ MM
Probl Endokrinol (Mosk); 1994; 40(3):52-4. PubMed ID: 8073007
[No Abstract] [Full Text] [Related]
20. Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: mechanistic studies.
Michna H; Schneider MR; Nishino Y; el Etreby MF
Breast Cancer Res Treat; 1989 Dec; 14(3):275-88. PubMed ID: 2514814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
